These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. Allday MJ; Crawford DH; Griffin BE J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663 [TBL] [Abstract][Full Text] [Related]
23. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies. Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223 [TBL] [Abstract][Full Text] [Related]
24. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. Kis LL; Takahara M; Nagy N; Klein G; Klein E Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314 [TBL] [Abstract][Full Text] [Related]
25. The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus. Kutz H; Reisbach G; Schultheiss U; Kieser A Virology; 2008 Feb; 371(2):246-56. PubMed ID: 17967471 [TBL] [Abstract][Full Text] [Related]
26. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. Katsumura KR; Maruo S; Takada K J Med Virol; 2012 Mar; 84(3):504-10. PubMed ID: 22246839 [TBL] [Abstract][Full Text] [Related]
27. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. Allday MJ; Crawford DH; Thomas JA J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171 [TBL] [Abstract][Full Text] [Related]
29. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques. Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452 [TBL] [Abstract][Full Text] [Related]
30. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids. Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993 [TBL] [Abstract][Full Text] [Related]
31. CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines. Pokrovskaja K; Ehlin-Henriksson B; Kiss C; Challa A; Gordon J; Gogolak P; Klein G; Szekely L Int J Cancer; 2002 Jun; 99(5):705-12. PubMed ID: 12115504 [TBL] [Abstract][Full Text] [Related]
32. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580 [TBL] [Abstract][Full Text] [Related]
33. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A; Pfaff P; Lange W; Finke J Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686 [TBL] [Abstract][Full Text] [Related]
34. Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab. Loomis R; Carbone R; Reiss M; Lacy J Clin Cancer Res; 2003 May; 9(5):1931-9. PubMed ID: 12738752 [TBL] [Abstract][Full Text] [Related]
35. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines. Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516 [TBL] [Abstract][Full Text] [Related]
36. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. Contreras-Brodin BA; Anvret M; Imreh S; Altiok E; Klein G; Masucci MG J Gen Virol; 1991 Dec; 72 ( Pt 12)():3025-33. PubMed ID: 1662694 [TBL] [Abstract][Full Text] [Related]
37. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
38. Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs. Canitano A; Venturi G; Borghi M; Ammendolia MG; Fais S Cancer Lett; 2013 Sep; 337(2):193-9. PubMed ID: 23684926 [TBL] [Abstract][Full Text] [Related]